As of yesterday, the XBI biotech index has not only reversed last month’s slump but reached the full-year high it set in April. And that’s despite the fact that drug pricing rhetoric has hardly subsided, and next year’s presidential election remains as unpredictable as ever.
Image: https://mailchi.mp